DNA Gene Chip Market, by DNA Type (cDNA Microarrays, Oligo DNA Microarrays, BAC Microarrays and SNP Microarrays), by Application (Drug Discovery, Genomics, Gene Expression, Environmental Control, Cancer Treatment and Diagnosis, Agricultural Biology, Others), by End-user (Hospitals and Clinical Diagnostic Centers, Pharmaceutical Companies, Research Laboratories, Academic & Research Institutes, Others) -Global Industry Insights, Trends and Forecast, 2017-2025

Created On: Jun-2018
Report ID: IR40
Format: PDF

DNA Gene Chip Market: Introduction

DNA gene chips also known as microarrays are minute chips that are inserted in the DNA molecules. The size of the chip is similar to that of a postcard stamp. Such powerful arrays are used in genetics and medical research due to their capacity to speed up the research process. DNA microarrays consist of microscopic DNA spots attached to a firm surface. DNA gene chips fine wide application in mapping geneID, genomic hybridization, profiling gene expression, and genotyping and re-sequencing in plats, human, eukaryotes and prokaryote genomes.

Owing to the positive growth trajectory of the DNA gene chip market, several new players looking to penetrate this market for significant expansion opportunities. Further, this market is expected to exhibit a double digit growth during the forecast period.

Market Dynamics

The rising need for early cancer detection and diagnosis is one of the key factors fuelling the growth of the DNA gene chip market at present. According to Insights and Reports, cancer accounted for second leading cause of death in 2016, and was responsible for more than 9 million deaths worldwide. More than 70% of the deaths caused by cancer occur in the middle and low income countries. High body mass index, dietary risks, low fruit and vegetable consumption, excess alcohol and tobacco use and lack of physical activities are the key reasons for cancer. Further, U.K. records more than 350,000 cases of cancer annually, which is equivalent to more than 950 cases on a daily basis. Cancer prevalence rates among the male population is higher compared to females. Moreover, cancer prevalence in the country is expected to maintain a growth of 2.7% annually till 2030. These factors have led to the rise in market growth of DNA gene chips due to the increasing demand for early stage diagnosis.

Rising demand for precision medicines is another key factor resulting in the growth of the DNE gene chips market at present. Precision medicines are developed based on the individual variability in genes, and the lifestyle of an individual. The benefits offered by precision medicine includes accurate prediction of the treatment coupled with prevention methods for a specific disease in an individual or a group of individuals. According to Insights and Reports, the global precision medicine market is expected to maintain a double digit growth in the coming years.

However, lack of per capita spending on healthcare in the developing and under developed regions is a major factor restraining the growth of the DNA gene chip market at present. Further, lack of healthcare infrastructure in the developing and under developed regions is another key factor holding back the growth of the market at present.

Market Segmentation and Analysis

Based on DNA type, the global DNA gene chip market has been classified into cDNA Microarrays, Oligo DNA Microarrays, BAC Microarrays and SNP Microarrays.

Further, based on application, the market has been classified into drug discovery, genomics, gene expression, environmental control, cancer treatment and diagnosis, and agricultural biology among others.

Moreover, based on end-user the market has been classified into hospitals and clinical diagnostic centers, pharmaceutical companies, research laboratories, and academic & research institutes among others.

Geographical Outlook

North America is expected to continue dominating the market throughout the forecast period from 2017-2025. Technological advancements are expected to drive the growth of the DNA gene chip market in the region. U.S. is the major contributor to the growth of the market. High per capita spending on healthcare in the U.S. is one of the key factors responsible for the growth of the DNA gene chip market in the country. According to Insights and Reports, healthcare spending per capita amounted to more than US$ 11,000 in 2018 as compared to US$ 8,871 in 2012. Moreover, cancer is one of the leading causes of death in the country. According to Insights and Reports, more than 1,700,000 cancer cases were diagnosed in the U.S. in 2017 and more than 600,000 people died due to the disease in the same year. These factors have stirred the demand for DNA gene chips in the country.

Asia Pacific is expected to exhibit promising growth in the field of DNA gene chip in the coming years with India, China and Japan spearheading the growth of the market. According to Insights and Reports, China recorded more than 3.2 million deaths due to cancer in 2016, with lung cancer being the common type of cancer in the country. Lung cancer, stomach cancer, liver cancer, breast cancer and colorectum cancer are common types of cancer that are prevalent in the country. Further, rising per capita healthcare spending in China is another key factor that is expected to push the growth of the DNA gene chip market in the country. According to Insights and Reports hospital healthcare services in the country amounted to more than US$ 300 billion in 2016. Rising demand for precision medicines in India is leading the growth of the DNA gene chip market in India. According to Insights and Reports, the precision medicine market in India was valued at an excess of US$ 45 billion in 2017. Rising prevalence of cancer is a leading factor responsible for the growth of the precision medicine market in India, which in turn is fuelling market growth of DNA gene chip in the country.

Competitive Landscape

Key players operating in the field of DNA gene chip market include Agilent Technologies Inc., Biomeriux S.A., Bioneer Corp, Affymetrix Inc., Illumina Inc., and Macrogen Inc. among others.

Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Reach Out to us